Studies of IGF-I as a marker of cardiovascular disease have yielded inconsistent results [2,3], however, one of the IGFBPs, IGFBP-1, has emerged as a more promising biomarker and is, therefore, the focus of this review. The gene discussed is IGF1; the disease is cardiovascular disorder.